Vincent Sapin is a Medical Biologist specialized in biochemistry and molecular biology. He is Professor at the Medicine School, University of Auvergne, Clermont-Ferrand, France. He is the Head of Biochemistry and Molecular Biology Department of the University Hospital of Clermont-Ferrand. He directed a fundamental research group called R2D2: Retinoids, Reproduction, Developmental Diseases at the University of Auvergne. The scientific field of this research group is focused on the obstetrical area, focusing on the studies of the metabolic and molecular implications of the retinoids (active derivatives of vitamin A/retinol) during normal and pathological human (lung and amniotic membranes) development. Considering the applied clinical research, he is working on the development and validation of biomarkers to improve the diagnosis, the following and the prognosis of different human pathologies. Recently, he worked on biomarkers in the field of premature ruptures of membranes (IGFBP-1), pediatric brain traumatic injury (S100 beta), renal failure (NGAL), acute lung injury (sRAGE), and fetal alcoholic syndrome.
Biography Updated on 30 April 2012